Nerelimomab
From Wikipedia, the free encyclopedia
Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Mouse |
Target | TNF alpha |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
KEGG |
|
NY (what is this?) |
Nerelimomab is a mouse monoclonal antibody acting as a TNF inhibitor.[1]
References[]
- ^ "WHO Drug Information" (PDF). Archived from the original (PDF) on 2012-02-19. Retrieved 2009-09-24.
Monoclonal antibodies for the immune system | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Immune system |
| ||||||||||
Interleukin |
| ||||||||||
Inflammatory lesions |
| ||||||||||
|
This monoclonal antibody–related article is a stub. You can help Wikipedia by . |
- v
- t
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Drugs not assigned an ATC code
- Monoclonal antibodies
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
Hidden categories:
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- All stub articles